Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection. Jansz TT, Young KG, Hopkins R, McGovern AP, et al. Diabetologia 2025 Nov 9. doi: 10.1007/s00125-025-06577.

Read + Share

Amedeo Smart

Independent Medical Education

Jansz TT, Young KG, Hopkins R, McGovern AP, et al. Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection. Diabetologia 2025 Nov 9. doi: 10.1007/s00125-025-06577.
PMID: 41206830